Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing | News
Search Refinements

Manufacturing News

View news from other Pharmaceutical sectors:
1-15 of 2230 results
Horizon to acquire GE's gene tech business Dharmacon
By PBR Staff Writer
Gene editing company Horizon Discovery Group (HDG) has agreed to acquire General Electric’s (GE) gene tech business Dharmacon for $85m.
Production & Manufacturing > Manufacturing > News
Emergent BioSolutions to buy GSK’s anthrax treatment raxibacumab
By PKBR Staff Writer
Emergent BioSolutions has agreed to acquire GlaxoSmithKline’s (GSK) anthrax monoclonal antibody, raxibacumab, for around $96m.
Production & Manufacturing > Manufacturing > News
CHMP issues positive opinion for Daiichi Sankyo's LIXIANA label update
The European Committee for Medicinal Products for Human Use (CHMP) has recommended approval of a label update for Daiichi Sankyo Europe's LIXIANA, to provide guidance on its use in patients undergoing transoesophageal echocardiography (TEE)-guided and delayed cardioversion.
Production & Manufacturing > Manufacturing > News
Lilly reaches settlement deal in US Cialis patent litigation
Eli Lilly and Company has entered into a settlement agreement with generic companies to resolve pending patent litigation in the U.S. District Court for the Eastern District of Virginia regarding the Cialis (tadalafil) unit dose patent.
Production & Manufacturing > Manufacturing > News
ABPI applies for Judicial Review against new procedures for cost-effective medicines
The Association of the British Pharmaceutical Industry (ABPI) has applied for judicial review over new procedures that restrict access to cost-effective medicines.
Production & Manufacturing > Manufacturing > News
Lilly wins Alimta vitamin regimen patent case in UK
By PBR Staff Writer
Eli Lilly and Company has been given a favourable ruling in the UK Supreme Court in the vitamin regimen patent litigation case relating to its cancer drug Alimta (pemetrexed disodium) against Actavis.
Production & Manufacturing > Manufacturing > News
Samsung Biologics to manufacture Sun Pharma’s psoriasis drug Tildrakizumab
By PBR Staff Writer
Indian drug major Sun Pharma has signed a manufacturing agreement with South Korea-based Samsung BioLogics for psoriasis experimental drug Tildrakizumab.
Production & Manufacturing > Manufacturing > News
FDA takes key steps under new drug competition action plan
By PBR Staff Writer
The US Food and Drug Administration (FDA) is taking two new key steps to increase competition in the market for prescription drugs and support entry of lower-cost alternatives.
Production & Manufacturing > Manufacturing > News
Pfizer breaks ground on new R&D facility in Missouri
Pfizer has broke ground on a research and development (R&D) and process development facility at 875 W. Chesterfield Parkway, Chesterfield in the US state of Missouri.
Production & Manufacturing > Manufacturing > News
Eli Lilly completes $90m expansion of biotechnology center in San Diego
Eli Lilly and Company has completed the $90m expansion of its biotechnology center in San Diego, California, US.
Production & Manufacturing > Manufacturing > News
Bristol-Myers Squibb to divest Irish manufacturing facility to SK Biotek
Bristol-Myers Squibb has agreed to divest its small molecule active pharmaceutical ingredient manufacturing facility in Swords, Ireland, to South Korea based SK Biotek, a subsidiary of SK Holdings.
Production & Manufacturing > Manufacturing > News
JSR Life Sciences to buy cell line developer Selexis
By PBR Staff Writer
JSR Life Sciences (JLS) has agreed to acquire life sciences firm and mammalian cell-line generation technologies provider Selexis for an undisclosed sum.
Production & Manufacturing > Manufacturing > News
FDA accepts Synergy’s sNDA for Trulance to treat adults with IBS-C
The US Food and Drug Administration (FDA) has accepted Synergy Pharmaceuticals’ supplemental New Drug Application (sNDA) Trulance (plecanatide) for the treatment of adults with irritable bowel syndrome with constipation (IBS-C).
Production & Manufacturing > Manufacturing > News
AstraZeneca to divest Zomig migrane drug rights for $302m
By PBR Staff Writer
German firm Grünenthal Group has agreed to acquire global rights of migraine treatment, Zomig (Zolmitriptan), from AstraZeneca for around $302m.
Production & Manufacturing > Manufacturing > News
Bristol-Myers’ opdivo approved in Europe for urothelial carcinoma
Bristol-Myers Squibb’s Opdivo (nivolumab) has been approved by the European Commission (EC) for the treatment of locally advanced unresectable or metastatic urothelial carcinoma (mUC) in adults after failure of prior platinum-based therapy.
Production & Manufacturing > Manufacturing > News
1-15 of 2230 results